title: Nicotine restores Wt-like levels of reelin and GAD67 gene expression in brain of heterozygous reeler mice.
abstract: Important reduction of reelin, a neural development- and plasticity-associated protein, and glutamic acid decarboxylase (GAD67) are reported in brains of schizophrenic patients. These individuals are consistently engaged in tobacco smoking and nicotine is thought to alleviate negative behavioral symptoms or cognitive alterations. In mouse brain, nicotine has been shown to reduce GAD67 promoter methylation and increase its transcription. We assessed the effects of administration of nicotine (1 mg/kg s.c.) for 6 days, in male mice heterozygous for reelin (HRM), a putative model for symptoms related to schizophrenia. Expression of reelin, GAD67 and brain-derived neurotrophic factor (BDNF) was measured in different brain areas. RNA expression analysis evidenced genotype-related changes, with a marked reduction in reelin and GAD67 gene expression in prefrontal cortex, hippocampus, cerebellum, and striatum from HRM. Nicotine treatment selectively reversed the HRM-related phenotype in most brain areas and increased BDNF gene expression in cortex and hippocampus of both genotypes. Locomotor performance in their home cage revealed that HRM subjects were characterized by general hyperactivity; with nicotine administration restoring WT-like levels of locomotion. These findings are interpreted within the hypothesis of pre-existing vulnerability (based on haploinsufficiency of reelin) to brain and behavioral disorders and regulative effects associated with nicotine exposure.
authors: Section of Behavioural Neuroscience, Department of Cell Biology & Neuroscience, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
authors: Emilia
authors: E
authors: Romano
authors: Andrea
authors: A
authors: Fuso
authors: Giovanni
authors: G
authors: Laviola
mesh_terms: D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000201:enzymology*; D005260:Female; D015971:Gene Expression Regulation, Enzymologic; D005968:Glutamate Decarboxylase / Q000096:biosynthesis*; D008297:Male; D051379:Mice; D008818:Mice, Neurologic Mutants; D009043:Motor Activity / Q000187:drug effects / Q000502:physiology; D009538:Nicotine / Q000494:pharmacology*; D000091042:Reelin Protein
chemical_list: D000091042:Reelin Protein; D009538:Nicotine; C000717128:Reln protein, mouse; D005968:Glutamate Decarboxylase; C402565:glutamate decarboxylase 1
references: Neuroscience. 2011 Aug 25;189:32-42
references: 21664258
references: J Perinat Med. 2009;37(5):553-60
references: 19492919
references: Novartis Found Symp. 2008;289:119-29; discussion 129-35, 193-5
references: 18497099
references: J Neurosci. 2000 Sep 15;20(18):7116-21
references: 10995859
references: Dev Biol. 2004 Apr 15;268(2):403-15
references: 15063176
references: Schizophr Res. 2010 Jun;119(1-3):47-51
references: 20096541
references: Neurosci Biobehav Rev. 2005;29(6):1021-34
references: 15964073
references: Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jul 1;32(5):1269-76
references: 18501492
references: Dev Biol. 1994 Sep;165(1):243-56
references: 8088442
references: Behav Brain Res. 2004 Aug 12;153(1):43-54
references: 15219705
references: Psychopharmacology (Berl). 2006 Aug;187(3):331-44
references: 16783542
references: Schizophr Res. 2008 Apr;101(1-3):58-66
references: 18289832
references: Nicotine Tob Res. 2000 Aug;2(3):263-74
references: 11082827
references: Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4407-11
references: 20150511
references: Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15718-23
references: 9861036
references: Respir Res. 2010 Oct 29;11:150
references: 21034448
references: Neurobiol Learn Mem. 2006 May;85(3):228-42
references: 16376115
references: J Biol Chem. 2002 Oct 18;277(42):39944-52
references: 12167620
references: Psychopharmacology (Berl). 2010 Oct;212(3):301-7
references: 20661552
references: Can J Psychiatry. 2005 Dec;50(14):892-900
references: 16494258
references: Mol Psychiatry. 2003 Jun;8(6):592-610
references: 12851636
references: Eur J Neurosci. 2004 Nov;20(10):2580-90
references: 15548201
references: Brain Res Mol Brain Res. 2000 Dec 28;85(1-2):234-8
references: 11146126
references: Neurosci Biobehav Rev. 2006;30(8):1065-77
references: 16769115
references: Mol Psychiatry. 2005 Jul;10(7):637-50
references: 15940304
references: Biochim Biophys Acta. 2009 Sep;1790(9):869-77
references: 19559755
references: Eur J Neurosci. 1996 Aug;8(8):1707-17
references: 8921261
references: Cell Mol Neurobiol. 2002 Apr;22(2):139-52
references: 12363196
references: Behav Pharmacol. 2004 Sep;15(5-6):341-52
references: 15343057
references: Nat Rev Neurosci. 2002 Sep;3(9):715-27
references: 12209120
references: J Neurosci. 2005 Sep 7;25(36):8209-16
references: 16148228
references: IDrugs. 2004 Dec;7(12):1096-103
references: 15599803
references: Biol Psychiatry. 2005 Apr 1;57(7):777-87
references: 15820235
references: J Neurosci. 2000 Nov 1;20(21):8087-95
references: 11050130
references: N Engl J Med. 2003 Oct 30;349(18):1738-49
references: 14585943
references: Curr Mol Pharmacol. 2010 Jan;3(1):12-29
references: 20030625
references: Eur J Neurosci. 1995 Feb 1;7(2):213-22
references: 7757258
references: Neuron. 1998 Aug;21(2):305-15
references: 9728912
references: Behav Neurosci. 2003 Dec;117(6):1257-75
references: 14674845
references: J Neurophysiol. 2007 Mar;97(3):2312-21
references: 17229826
references: Mol Neurobiol. 2003 Aug;28(1):1-22
references: 14514983
references: Arch Gen Psychiatry. 2000 Mar;57(3):237-45
references: 10711910
references: J Neurosci. 2003 Jul 9;23(14):6123-31
references: 12853431
references: Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4676-81
references: 17360583
references: Psychopharmacology (Berl). 2006 Nov;189(1):95-104
references: 16977475
references: Neuropsychopharmacology. 2002 Aug;27(2):212-24
references: 12093595
references: Brain Res. 2007 Feb 2;1131(1):173-80
references: 17174287
references: Neurobiol Dis. 2009 Oct;36(1):103-15
references: 19595767
references: Prog Neuropsychopharmacol Biol Psychiatry. 2010 Oct 1;34(7):1259-65
references: 20638435
references: Ann Ist Super Sanita. 1988;24(4):559-62
references: 3218804
references: Mol Cell Neurosci. 2008 Apr;37(4):731-46
references: 18243734
references: Eur J Neurosci. 2002 Apr;15(7):1197-205
references: 11982630
references: Neuropharmacology. 2012 Mar;62(3):1564-73
references: 21288470
references: Schizophr Res. 2008 Mar;100(1-3):325-33
references: 18187310
references: J Neurosci. 2002 Sep 1;22(17):7580-5
references: 12196581
references: Neurosci Biobehav Rev. 1999 Nov;23(7):993-1010
references: 10580313
references: Int Rev Cytol. 2002;213:1-47
references: 11837891
references: Neurosci Biobehav Rev. 2011 Aug;35(8):1631-3
references: 21645542
references: J Neurosci. 1998 Sep 15;18(18):7256-71
references: 9736647
references: J Neurobiol. 2002 Dec;53(4):590-605
references: 12436423
references: Arch Gen Psychiatry. 2000 Nov;57(11):1061-9
references: 11074872
references: Science. 1997 Jan 3;275(5296):83-6
references: 8974398
references: Neurobiol Dis. 2001 Oct;8(5):723-42
references: 11592844
references: Drug Alcohol Depend. 2005 Nov 1;80(2):259-65
references: 15869844
references: Am J Med Genet B Neuropsychiatr Genet. 2005 Apr 5;134B(1):60-6
references: 15717292
references: Mol Psychiatry. 1999 Mar;4(2):163-72
references: 10208448
references: Psychiatr Clin North Am. 2003 Mar;26(1):25-40
references: 12683258
references: Horm Behav. 2011 Mar;59(3):315-20
references: 20483357
references: Neurochem Res. 2006 Apr;31(4):579-84
references: 16758368
references: Schizophr Bull. 2013 Sep;39(5):1067-76
references: 22941745
references: Schizophr Res. 2007 Mar;91(1-3):51-61
references: 17270400
references: Mol Psychiatry. 2007 Apr;12(4):385-97
references: 17264840
references: Mol Pharmacol. 2011 Jul;80(1):174-82
references: 21505039
references: Neuroreport. 1999 Apr 26;10(6):1329-34
references: 10363948
references: Annu Rev Neurosci. 2002;25:409-32
references: 12052915
references: Biochem Pharmacol. 2007 Oct 15;74(8):1192-201
references: 17714692
references: Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17095-100
references: 12481028
references: Eur J Neurosci. 2011 Feb;33(3):383-90
references: 21198979
references: Nature. 1995 Apr 20;374(6524):719-23
references: 7715726
references: Behav Brain Res. 2011 Aug 10;221(2):623-9
references: 21457731
references: J Nutr Biochem. 2011 Mar;22(3):242-51
references: 20573497
references: Front Biosci. 2008 Jan 01;13:492-504
references: 17981563
references: Mol Interv. 2002 Feb;2(1):47-57
references: 14993361
references: Biochem Pharmacol. 2007 Oct 15;74(8):1182-91
references: 17714691
references: Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3477-82
references: 11248103
references: Psychopharmacology (Berl). 2007 Mar;190(4):433-9
references: 17186223
references: Folia Med (Plovdiv). 2012 Apr-Jun;54(2):12-6
references: 23101279
references: Cereb Cortex. 1995 Nov-Dec;5(6):550-60
references: 8590827
references: Environ Health Perspect. 2003 Apr;111(4):395-401
references: 12676589
references: Nat Rev Neurosci. 2006 Nov;7(11):850-9
references: 17053810
references: Psychoneuroendocrinology. 2010 Oct;35(9):1374-87
references: 20452127
references: Mol Pharmacol. 2007 Mar;71(3):644-53
references: 17065238
references: Am J Psychiatry. 1986 Aug;143(8):993-7
references: 3487983
references: Neuron. 2005 Aug 18;47(4):567-79
references: 16102539
references: Cell Mol Neurobiol. 2007 Aug;27(5):609-39
references: 17554626
references: Eur J Pharmacol. 1993 Jul 6;238(1):1-8
references: 8405072
references: Psychiatry Res. 2002 Jul 31;110(3):249-57
references: 12127475
references: Neurosci Biobehav Rev. 2009 Apr;33(4):560-72
references: 18845182
references: Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16356-61
references: 18852456
references: Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9341-6
references: 15961543
references: Mol Psychiatry. 2000 Nov;5(6):654-63, 571
references: 11126396